Anti-Aging Market Size to Surpass USD 284.8 billion by 2028, exhibiting a CAGR of 4.4% | Report by Transparency Market Research
October 06, 2023 04:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The anti-aging market is projected to reach US$ 284.8 billion by 2028. Anti-aging market...
GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions
October 05, 2023 08:45 ET
|
GRI Bio, Inc.
In several murine models of chronic inflammation and fibrosis, as well as in humans, it has been shown that iNKT cells are selectively activated in the disease setting Data supports GRI Bio’s...
Exploring the Future of Healthcare: Mobile Hospitals Market Set to Reach USD 52.8 Billion by 2031 - TMR Analysis
September 15, 2023 08:04 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global mobile hospitals market is projected to flourish at a CAGR of 10% from 2021 to...
[Latest] Global Biofilms Treatment Market Size/Share Worth USD 3.5 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
September 05, 2023 16:30 ET
|
Custom Market Insights
Austin, TX, USA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Biofilms Treatment Market Size, Trends and Insights By Product (Debridement...
Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors
August 17, 2023 08:30 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers...
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
August 16, 2023 08:00 ET
|
QSAM Biosciences Inc.
AUSTIN, Texas, Aug. 16, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections
August 10, 2023 08:00 ET
|
US Capital Global
San Francisco, California, USA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, recently launched an investment opportunity of up to $5 million...
APA Foundation Encourages Action with First Major Mental Health Public Awareness Initiative
August 09, 2023 10:00 ET
|
American Psychiatric Association
Washington, D.C., Aug. 09, 2023 (GLOBE NEWSWIRE) -- The American Psychiatric Association Foundation (APAF) launched a transformative awareness campaign that empowers individuals to take the first...
Las Vegas Alcohol Rehab
August 07, 2023 10:00 ET
|
Gallus Medical Detox Centers
LAS VEGAS, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Gallus Medical Detox Center in Las Vegas, a leading provider of medically supervised detoxification services, is proud to share more on its alcohol detox...
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
July 31, 2023 16:05 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development...